Dr. Jamie Frankish presented at ISCT Vancouver 2024. “Novel non-viral delivery technology, Solupore®, enables gene delivery for a healthier, more potent, and significantly more effective CAR-T therapy in vivo.”

Latest News

Find out all the latest news with Acevtas!

Avectas New Labs In Cherrywood
Avectas Opens new Labs in Cherrywood
The Advanced Therapies Week 2024 Miami, featured our own Dr. Lisa O’Flynn as a guest speaker at the Non-Viral Solutions for Gene Therapy Session.
Ann Brady
Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer
Solupore
Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
Bitmap
Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology
Hand Holding Test Vial
Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors
DNA Strand
GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process
White Cells
AVECTAS leading the way in non-viral cell engineering technology
Avectas New Labs In Cherrywood
Avectas Opens new Labs in Cherrywood
The Advanced Therapies Week 2024 Miami, featured our own Dr. Lisa O’Flynn as a guest speaker at the Non-Viral Solutions for Gene Therapy Session.
Ann Brady
Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer
Solupore
Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
Bitmap
Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology
Hand Holding Test Vial
Inceptor Bio and Avectas Announce Collaboration to Improve Manufacturing of CAR-T Cell Therapies for the Treatment of Solid Tumors
DNA Strand
GenScript and Avectas Team Up to Improve the Non-Viral Cell Therapy Manufacturing Process
White Cells
AVECTAS leading the way in non-viral cell engineering technology